KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Depreciation & Amortization (CF) (2016 - 2024)

Historic Depreciation & Amortization (CF) for Palvella Therapeutics (PVLA) over the last 11 years, with Q1 2024 value amounting to -$30000.0.

  • Palvella Therapeutics' Depreciation & Amortization (CF) fell 10495.87% to -$30000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was -$30000.0, marking a year-over-year decrease of 10157.56%. This contributed to the annual value of $1.9 million for FY2023, which is 3126.35% down from last year.
  • Palvella Therapeutics' Depreciation & Amortization (CF) amounted to -$30000.0 in Q1 2024, which was down 10495.87% from -$198000.0 recorded in Q4 2023.
  • Palvella Therapeutics' 5-year Depreciation & Amortization (CF) high stood at $845000.0 for Q1 2022, and its period low was -$198000.0 during Q4 2023.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $609000.0 (2021), whereas its average is $553764.7.
  • As far as peak fluctuations go, Palvella Therapeutics' Depreciation & Amortization (CF) surged by 116190.48% in 2020, and later plummeted by 13443.48% in 2023.
  • Palvella Therapeutics' Depreciation & Amortization (CF) (Quarter) stood at $688000.0 in 2020, then decreased by 11.48% to $609000.0 in 2021, then fell by 5.58% to $575000.0 in 2022, then tumbled by 134.43% to -$198000.0 in 2023, then surged by 84.85% to -$30000.0 in 2024.
  • Its last three reported values are -$30000.0 in Q1 2024, -$198000.0 for Q4 2023, and $739000.0 during Q3 2023.